Toft Group Executive Search Places Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY.

Lori Batta was previously Chief Commercial Officer at Celmatix, Inc., a next generation women’s health company. Prior to Celmatix, Batta served as Senior Vice President, Business Development and Strategic Alliances at Good Start Genetics (GSG), where she led the company’s global business development strategy. During her time at GSG, Batta was responsible for the launch of the first next-generation sequencing carrier screen and drove more than $100M in revenue in its first three years in the market. 

Batta also served as Senior Director, Commercial with Javelin Pharmaceutical, where she directed regulatory and commercialization strategy for the Javelin Pain Franchise for three late-stage specialty pain products. Before Javelin, she served as Vice President of Sales and Marketing for MDR Specialty Pharma, and Vice President of Sales, Reproductive Health for EMD Serono.

Batta holds a B.A. in Biology from College of St. Elizabeth, Convent Station, NJ.

About TMRW
In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births—almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market enthusiasm, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced the concept of TMRW’s risk-mitigating RPA platform as a replacement for current less sophisticated analog IVF cryo-management systems. TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.

TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. www.tmrw.org 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Places Peg Taylor as Vice President, Clinical Operations at Adicet Bio, Inc. in Menlo Park, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Peg Taylor as Vice President, Clinical Operations at Adicet Bio, Inc. in Menlo Park, CA.

Peg Taylor most recently served as Senior Director, Clinical Operations at Nektar Therapeutics. Previously, she served in progressive clinical roles at Genentech, most recently as Program Group Director. There, she led the program execution of all Clinical Operations for a portfolio of molecules in early development.

Prior to Genentech, Taylor was Senior Director at Bayhill Therapeutics where she led clinical operations for a virtual biotech company focused on autoimmune disease assets. Earlier, she served as Oncology Clinical Program Director for Quintiles (now IQVIA), where she supported various studies focused on tumors including NSCLC, Glioblastoma, GI Stromal Tumors and MBC. 

Taylor holds a B.S. in Nutrition Science from University of California, Davis.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. Adicet is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors or T Cell Receptors (TCRs). Adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating TCR-like MAbs (TCRLs) directed to these cancer-specific peptide targets presented by MHC Class I complexes. In August 2016, Adicet entered a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop next-generation engineered immune-cell therapeutics using Adicet’s gamma delta T cell allogeneic platform technology. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA.

Dr. Jessica Riley served as Senior Director, Business Development at Guardant Health where she led business collaborations with Pharmaceutical companies for the development and commercialization of Next Generation Sequencing Liquid Biopsy products, as well as Companion Diagnostic programs. She joined Guardant from Leica Biosystems where she served as Senior Director, Business Development, Pharma Partnerships. Previously, Dr. Riley held progressive roles with Qiagen, most recently as Director of Assay Development. 

Dr. Riley’s career began at St. James’s University Hospital as a Clinical Genetics Scientist. She holds a Ph.D. in Bio-production & Characterization of Self-Assembling Peptides from the University of Leeds, UK, and a B.S in Molecular & Cellular Biology from the University of Huddersfield, UK.

About PathAI
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Jon Buncab as Vice President Market Access at Millennium Health in San Diego, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jon Buncab as Vice President Market Access at Millennium Health in San Diego, CA.

Jon Buncab has served as Senior Director of Market Access and Reimbursement Strategy at Genoptix where he was responsible for payer, health system and laboratory support of their oncology portfolio, implementing strategic expertise regarding market access and reimbursement. Notably, he contributed to the successful launch of the MRDx® BCR-ABL Test, the first companion diagnostic promoted by Genoptix.

Previously, Buncab was Executive Director, Head of Payer Strategy, Reimbursement and Client Operations at Prometheus Laboratories. There, he led market access field teams in therapeutic and diagnostic payer, health system, hospital and laboratory strategy for both gastroenterology and oncology product portfolios and client operations. He also served as Director of Managed Care West for CardioDx, establishing diagnostic medical policy and managed care contracts for Corus CAD® in the West Region. Before that, he was the National Director, Managed Markets/Sales for Exagen Diagnostics, where he led field sales for this rheumatology specialty company focused on unmet needs. 

About Millennium Health
Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically actionable information through our nationwide medication monitoring and drug testing services. Drug testing is used by substance use disorder and pain management providers to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Robin Toft’s WE CAN: The Executive Woman’s Guide to Career Advancement Recognized Within List of 100 Best CEO Books of All Time by BookAuthority

The best CEO books of all time
SAN FRANCISCO, July 9, 2019 Toft Group Executive Search, a global life sciences and healthcare executive search firm, today announced that its Chairman and CEO, Robin Toft, has been recognized on BookAuthority’s list of 100 Best CEO Books of All Time for her recently launched professional development book titled WE CAN: The Executive Woman’s Guide to Career Advancement. WE CAN provides valuable insights to empower women to quickly navigate to the career of their dreams. 

“I am incredibly honored to have made this prestigious list of best CEO books of all time,” said Robin Toft. “This recognition as one of the best books for professional development highlights my aspiration to empower women in their lives to achieve their dreams.”

The full list of 100 Best CEO Books of all time can be found here, and WE CAN: The Executive Woman’s Guide to Career Advancement can be purchased on Amazon.

As featured on CNN, Forbes and Inc, BookAuthority is the world’s leading site for nonfiction book recommendations for the best books for personal development. BookAuthority uses a proprietary technology to identify and rate the best nonfiction books, using dozens of different signals, including public mentions, recommendations, ratings, sentiment, popularity and sales history. This includes maintaining the most comprehensive collection of book recommendations from domain experts such as Elon Musk, Warren Buffett, Prof. Daniel Kahneman, Sheryl Sandberg, and David Allen.

About WE CAN

Becoming an executive is no easy task. Becoming a female executive is something else altogether. How can the ambitious woman excel, advance, and thrive in seemingly male-dominated industries with thousands of years of history working against her?

Through her own inspiring journey from employee to powerful female executive, Robin Toft shares the wisdom she gleaned at the boardroom table as an executive with over a decade of experience in executive search as Founder and CEO of the award-winning Toft Group. No matter where you are on your executive journey, Robin Toft will move you to action and empower you as a trusted partner through every aspect of your career advancement. Part manual and part memoir, WE CAN provides the confidence, language, and tools to design and realize the career of your dreams. Land the job, make vertical moves, and secure a seat at the boardroom table.

About Robin Toft

Upon founding Toft Group in 2010, Robin essentially launched a second career, following more than two decades as a biotech executive. She was awarded Woman of the Year in San Diego in 2017, in 2018 and 2019 she was a finalist in Ernst & Young’s prestigious Entrepreneur of the Year awards, and she’s been honored as a finalist for San Diego Business Journal’s “Women Who Mean Business” and “Most Admired CEO” awards in multiple years. Robin’s work with Toft Group combines a deep inside knowledge of the life science industry with a passion for building game-changing management teams.

About Toft Group Executive Search

Toft Group is a global life sciences and healthcare executive search firm specializing in diversity and a focus on innovation-driven companies at the intersection of biotech and high tech. Toft Group’s targeted, accurate searches translate into exceptional return-on-investment for clients nationwide, and the team’s extensive networks enable the presentation of more highly qualified and diverse candidates than clients would otherwise see. The firm’s extensive track record has shown its ability to quickly fill highly specialized leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Diego, San Francisco and Boston. For more information, please visit thetoftgroup.com.

Toft Group Executive Search Places Patricia Sandler as National Sales Director at OPKO Health, Inc. in Miami, FL

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Patricia Sandler as National Sales Director at OPKO Health, Inc. in Miami, FL.

Ms. Sandler previously served as Field Vice President at GlaxoSmithKline (GSK) overseeing a large team, promoting their respiratory inhaler portfolio. Before GSK, Sandler led commercial operations at Omeros Corporation, managing the comprehensive reimbursement support program and launch. She also previously held progressive commercial roles at Sunovion Pharmaceuticals, including Sales Team Lead for the respiratory portfolio, Interim Marketing Lead managing a product launch and prior as Executive Director, CNS Marketing for Lunesta brand.  Sandler also drove marketing and sales activities within the gastroenterology portfolio at Johnson & Johnson.

Sandler holds a BS. in business administration from Bloomsburg University of Pennsylvania.

About OPKO Health, Inc.
OPKO Health is a diversified healthcare company. In diagnostics, its BioReference Laboratories is the nation’s third largest clinical laboratory; GeneDx is a rapidly growing genetic testing business; the 4Kscore® prostate cancer test is used to confirm an elevated PSA to help decide about next steps such as prostate biopsy; Claros® 1 is a point-of-care diagnostics platform with a total PSA test approved by the FDA and testosterone as the most advanced test in development. In the pharmaceutical pipeline, RAYALDEE is their first pharmaceutical product to be marketed.  OPK88003, a once-weekly oxyntomodulin for type 2 diabetes and obesity recently reported positive data from a Phase 2 clinical trial.  It’s among a new class of GLP-1/glucagon receptor dual agonists.  OPK88004, a SARM (selective androgen receptor modulator) is currently being studied for various potential indications.  The Company’s most advanced product utilizing its CTP technology, a once-weekly human growth hormone for injection, is in Phase 3 trials, and is partnered with Pfizer.  OPKO also has research, development, production and distribution facilities abroad.  

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.

Toft Group Executive Search Successfully Places Grace Colón, Ph.D. on Board of Directors for CareDx, Inc. in Brisbane, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Grace Colón, Ph.D, on the Board of Directors for CareDx, Inc. in Brisbane, CA.

Dr. Colón has served as President, Chief Executive Officer and Director of InCarda Therapeutics, Inc., a clinical stage company developing therapeutics for cardiovascular conditions since 2013. In addition to her role at InCarda, she is also Executive Chairman (formerly CEO) of ProterixBio and is on the board of Cocoon Biotech. Previously, she served on the boards of Paradigm Diagnostics and PerceptiMed. She was formerly a partner at New Science Ventures and held various leadership roles at Intrexon Corporation, Gilead Sciences and Affymetrix. Earlier in her career, she was an engagement manager with McKinsey & Co.

Dr. Colón is a native of San Juan, Puerto Rico. She received her Ph.D. in chemical engineering from the Massachusetts Institute of Technology, where she conducted doctoral and post-doctoral research on metabolic engineering of industrial amino acids. She also holds a B.S. degree in chemical engineering from the University of Pennsylvania, where she was a Benjamin Franklin Scholar.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum and is the leading provider of genomics-based information for transplant patients.

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Executive Search Successfully Places Jane Wasman on Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jane Wasman on the Board of Directors for Rigel Pharmaceuticals in South San Francisco, CA. Ms. Wasman is a strategic leader with over 20 years of experience in the biopharma industry working with both large multinational corporations and privately held start-ups. Her expertise includes strategic development, corporate governance, litigation, commercialization, compliance and government affairs, and operational implementation.

Ms. Wasman currently serves as President, International and General Counsel at Acorda Therapeutics. Prior to joining Acorda, Ms. Wasman held various leadership positions at Schering-Plough Corporation, including Staff Vice President and Associate General Counsel. Previously, she was an attorney at two global law firms and Associate Counsel for the U.S. Senate Veterans’ Affairs Committee. Ms. Wasman is Chair of the Board of Sellas Life Sciences and serves on the board of the non-profit NewYorkBIO.

Ms. Wasman graduated magna cum laude from Princeton University, and earned her J.D. from Harvard Law School.

About Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel’s pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company’s first FDA approved product is TAVALISSE® (fostamatinib disodium hexahydrate), the only oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. Rigel’s clinical programs include an upcoming Phase 3 study of fostamatinib in autoimmune hemolytic anemia and an ongoing Phase 1 study of R835, a proprietary molecule from its interleukin receptor associated kinase (IRAK) program. In addition, Rigel has product candidates in clinical development with partners BerGenBio ASA, Daiichi Sankyo, Aclaris Therapeutics and AstraZeneca.

 About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Executive Search Successfully Places Magda Marquet, Ph.D. on Board of Directors for Pfenex Inc. in San Diego, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Magda Marquet, Ph.D. on the Board of Directors for Pfenex Inc. in San Diego, CA. Dr. Marquet was also appointed to serve as a member of the corporate governance and nominating committee.

Dr. Marquet co-founded Althea Technologies and led the company as co-CEO for ten years. Currently, Dr. Marquet is the co-Founder and co-CEO of ALMA Life Sciences, an early stage investment firm focusing on the creation and growth of innovative healthcare companies. Dr. Marquet is also the co-founder of AltheaDx, a commercial stage precision medicine company with the world’s leading pharmacogenomics test for anxiety and depression.

Dr. Marquet serves as a board member of Arcturus Therapeutics. She is an advisor to Mesa Verde Venture Partners and City National Bank. Dr. Marquet serves on several non-profit boards, including BIOCOM, CONNECT, EDC and Moores Cancer Center at UC San Diego. She holds a Ph.D. in Biochemical Engineering from INSA/University of Toulouse, France.

About Pfenex, Inc.

Pfenex, Inc. is a clinical-stage development and licensing biotechnology company focused on leveraging the Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs. Using the patented Pfēnex Expression Technology platform, they have created an advanced pipeline of therapeutic equivalents, vaccines, biologics and biosimilars.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

 

Toft Group Executive Search Places Andrea Chow, PhD as Senior Vice President of Engineering at Two Pore Guys, Inc. in Santa Cruz, CA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has placed Andrea Chow, PhD as Senior Vice President of Engineering at Two Pore Guys, Inc. in Santa Cruz, CA.

Dr. Chow has over 25 years of broad R&D experience in the life science and aerospace industries, developing leading edge technologies in microfluidics, microfabrication, biomolecular transport, detection instrumentation and advanced material processing.  She formerly served as the VP of Measurements and Engineering at BioElectron. Previously, Dr. Chow was with Promega as their Sr. Director of Integrated Engineering. Prior to Promega, she was the Co-Founder, Chief Financial Officer & Chief Operating Officer of Caerus Molecular Diagnostics. She co-founded this startup focused on low-cost and high accuracy DNA sequencing technologies. She has also served as an Engineering Consultant to various life science and medical device companies in relation to product and business development.

Dr. Chow was named among “100 Chemical Engineers of the Modern Era” by the American Institute of Chemical Engineers. Dr Chow has a PhD in Chemical Engineering from Stanford University.

About Two Pore Guys, Inc.

Two Pore Guys, Inc. develops single molecule biosensors for diagnostic uses. The company focuses on developing digital, hand-held, and single molecule biosensors that detect viruses, bacteria, antibodies, and other pathogens; and track disease progression.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.